Vesa Juvonen

6.7k total citations
43 papers, 1.7k citations indexed

About

Vesa Juvonen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Hematology. According to data from OpenAlex, Vesa Juvonen has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 10 papers in Hematology. Recurrent topics in Vesa Juvonen's work include Mitochondrial Function and Pathology (18 papers), Genetic Neurodegenerative Diseases (14 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Vesa Juvonen is often cited by papers focused on Mitochondrial Function and Pathology (18 papers), Genetic Neurodegenerative Diseases (14 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Vesa Juvonen collaborates with scholars based in Finland, Sweden and Norway. Vesa Juvonen's co-authors include Kirsi Huoponen, Tarja Lamminen, Eeva Nikoskelainen, Marja‐Liisa Savontaus, Kari Nummelin, Veli Kairisto, Pirkko Sonninen, M L Savontaus, R. J. Marttila and Satu Mustjoki and has published in prestigious journals such as Nature Genetics, Blood and PLoS ONE.

In The Last Decade

Vesa Juvonen

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesa Juvonen Finland 22 1.2k 433 307 244 229 43 1.7k
Suzanne Lam Netherlands 16 838 0.7× 257 0.6× 27 0.1× 99 0.4× 24 0.1× 22 1.3k
Mark D. Ludman Canada 20 446 0.4× 52 0.1× 78 0.3× 39 0.2× 74 0.3× 41 1.2k
Sibel Kantarci United States 15 821 0.7× 142 0.3× 53 0.2× 49 0.2× 41 0.2× 23 1.8k
Friedmar R. Kreuz Germany 17 498 0.4× 441 1.0× 20 0.1× 129 0.5× 71 0.3× 30 923
Anas M. Alazami Saudi Arabia 22 857 0.7× 118 0.3× 52 0.2× 46 0.2× 43 0.2× 55 1.5k
Tamilla Nechiporuk United States 17 1.4k 1.2× 970 2.2× 24 0.1× 487 2.0× 209 0.9× 24 1.8k
Brigitte Gilbert‐Dussardier France 19 636 0.5× 118 0.3× 71 0.2× 60 0.2× 15 0.1× 48 1.4k
Marc Valentine United States 19 932 0.8× 156 0.4× 11 0.0× 526 2.2× 67 0.3× 31 1.7k
Christel Thauvin‐Robinet France 21 762 0.6× 155 0.4× 95 0.3× 78 0.3× 29 0.1× 80 1.4k
Süleyman Gülsüner United States 21 795 0.7× 84 0.2× 43 0.1× 98 0.4× 184 0.8× 43 1.7k

Countries citing papers authored by Vesa Juvonen

Since Specialization
Citations

This map shows the geographic impact of Vesa Juvonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesa Juvonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesa Juvonen more than expected).

Fields of papers citing papers by Vesa Juvonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesa Juvonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesa Juvonen. The network helps show where Vesa Juvonen may publish in the future.

Co-authorship network of co-authors of Vesa Juvonen

This figure shows the co-authorship network connecting the top 25 collaborators of Vesa Juvonen. A scholar is included among the top collaborators of Vesa Juvonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesa Juvonen. Vesa Juvonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreutzman, Anna, Peter Rohoň, Edgar Faber, et al.. (2011). Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile. PLoS ONE. 6(8). e23022–e23022. 35 indexed citations
2.
Kreutzman, Anna, Vesa Juvonen, Veli Kairisto, et al.. (2010). Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy. Blood. 116(5). 772–782. 124 indexed citations
3.
4.
Mononen, Tarja, et al.. (2007). A novel duplication in the FMR1 gene: implications for molecular analysis in fragile X syndrome and repeat instability. Clinical Genetics. 72(6). 528–531. 10 indexed citations
5.
Hämäläinen, Mauri M., Veli Kairisto, Vesa Juvonen, et al.. (2007). Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia. European Journal Of Haematology. 80(3). 201–207. 22 indexed citations
6.
Hakonen, Anna H., Vesa Juvonen, Petri Luoma, et al.. (2005). Mitochondrial DNA Polymerase W748S Mutation: A Common Cause of Autosomal Recessive Ataxia with Ancient European Origin. The American Journal of Human Genetics. 77(3). 430–441. 227 indexed citations
7.
Mykkänen, Kati, Marja‐Liisa Savontaus, Vesa Juvonen, et al.. (2004). Detection of the founder effect in Finnish CADASIL families. European Journal of Human Genetics. 12(10). 813–819. 43 indexed citations
8.
Juvonen, Vesa, et al.. (2003). A novel sequence variation in the transactivation regulating domain of the androgen receptor in two infertile Finnish men. Fertility and Sterility. 79. 1647–1648. 20 indexed citations
9.
Udd, Bjarne, Vesa Juvonen, Peter M. Andersen, et al.. (2001). Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. European Journal of Human Genetics. 9(6). 431–436. 32 indexed citations
10.
Aula, Nina, et al.. (2001). Prenatal detection of free sialic acid storage disease: genetic and biochemical studies in nine families. Prenatal Diagnosis. 21(5). 354–358. 7 indexed citations
11.
Juvonen, Vesa, et al.. (2001). Dissecting the epidemiology of a trinucleotide repeat disease – example of FRDA in Finland. Human Genetics. 110(1). 36–40. 28 indexed citations
12.
Suikkari, Anne‐Maria, et al.. (2001). Y-chromosomal microdeletions among infertile Finnish men. Acta Obstetricia Et Gynecologica Scandinavica. 80(7). 652–656. 8 indexed citations
13.
Udd, Bjarne, Vesa Juvonen, Peter M. Andersen, et al.. (2000). Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia. European Journal of Human Genetics. 8(8). 631–636. 18 indexed citations
14.
Lamminen, Tarja, Kirsi Huoponen, Pertti Sistonen, et al.. (1998). mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy.. PubMed. 5(5). 271–9. 50 indexed citations
15.
Silander, Kaisa, Vesa Juvonen, Jaakko Ignatius, et al.. (1998). Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Human Mutation. 12(1). 59–68. 69 indexed citations
16.
Juvonen, Vesa, Eeva Nikoskelainen, Tarja Lamminen, et al.. (1997). Tissue distribution of the ND4/11778 mutation in heteroplasmic lineages with Leber hereditary optic neuropathy. Human Mutation. 9(5). 412–417. 18 indexed citations
17.
Majander, Anna, Tarja Lamminen, Vesa Juvonen, et al.. (1997). Mutations in subunit 6 of the F1F0‐ATP synthase cause two entirely different diseases. FEBS Letters. 412(2). 351–354. 22 indexed citations
18.
Nikoskelainen, Eeva, et al.. (1996). Ophthalmologic Findings in Leber Hereditary Optic Neuropathy, with Special Reference to mtDNA Mutations. Ophthalmology. 103(3). 504–514. 150 indexed citations
19.
Huoponen, Kirsi, Vesa Juvonen, Antti Iitiä, et al.. (1994). Time-resolved fluorometry in the diagnosis of Leber hereditary optic neuroretinopathy. Human Mutation. 3(1). 29–36. 10 indexed citations
20.
Juvonen, Vesa, et al.. (1994). Quantification of point mutations associated with Leber hereditary optic neuroretinopathy by solid-phase minisequencing. Human Genetics. 93(1). 16–20. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne Lam Breakdown of academic impact, for papers by Mark D. Ludman Breakdown of academic impact, for papers by Sibel Kantarci Breakdown of academic impact, for papers by Friedmar R. Kreuz Breakdown of academic impact, for papers by Anas M. Alazami Breakdown of academic impact, for papers by Tamilla Nechiporuk Breakdown of academic impact, for papers by Brigitte Gilbert‐Dussardier Breakdown of academic impact, for papers by Marc Valentine Breakdown of academic impact, for papers by Christel Thauvin‐Robinet Breakdown of academic impact, for papers by Süleyman Gülsüner
Rankless by CCL
2026